Schaeffer's Top Stock Picks for '25

Will the Dow Make History Today With 14 Straight?

The S&P 500 and Nasdaq are firmly higher this afternoon

Digital Content Manager
Jul 27, 2023 at 12:01 PM
facebook X logo linkedin


The Dow Jones Industrial Average (DJI) could match its longest win streak since June 1987 today with a 14th consecutive win. The blue-chip index is slightly above breakeven at midday, while both the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are higher after another batch of earnings. Also in focus is the latest gross domestic product (GDP) reading, which rose a better-than-expected 2.4% during the second quarter, while the personal consumption expenditures (PCE) price index saw a 2.6% pop that was smaller than analysts' estimates.

Continue reading for more on today's market, including: 

  • Meta Platforms stock surges after beat-and-raise.
  • Options traders blast fast food stock after earnings.
  • Plus, QS calls red-hot; construction stock hits record highs; and Biohaven stock sinks on FDA snub.

MMC Stats 0727

Quantumscape Corp (NYSE:QS) is seeing unusual options activity today, with 101,000 calls and 25,000 puts traded so far, which is 14 times the intraday average volume. Most popular is the weekly 7/28 11-strike call, where new positions are being opened. Shares are up 27.5% at $11.95 at last check, after the lithium metal battery company yesterday announced slimmer-than-expected second-quarter losses. The security earlier hit its highest level in 11 months, and is up 110.6% this year.

 

North American Construction Group Ltd (NYSE:NOA) is toward the top of the New York Stock Exchange (NYSE), last seen up 36.9% at $25.85. This bull gap comes after the company's second-quarter results beat analysts' expectations. The stock earlier surged to a record high of $26.01, blasting through a long-term ceiling at the $20 region amid two price-target hikes and a TD Securities upgrade to "buy" from "hold." NOA is up 93.4% in 2023.

 

NOA Intraday

Biohaven Ltd (NYSE:BHVN) stock is down 26.1% to trade at $17.59 at last check, at the bottom of the NYSE. The U.S. Food and Drug Administration (FDA) told the biotech name it would not review a marketing application for its genetic disorder treatment after it failed to meet the main goal of a late-stage study. BHVN is now trading at its lowest level since early May, but remains up 28.2% in 2024.
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?